# Preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument, Base plus two (2) option years

Canonical: https://abierto.us/opportunities/75f40126q135706

- Solicitation number: 75F40126Q135706
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Global Life Sciences Solutions USA LLC
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 811210 Electronic and Precision Equipment Repair and Maintenance
- Product or service code: J066 Maintenance, Repair and Rebuilding of Equipment: Instruments and Laboratory Equipment
- First posted: July 27, 2026
- Last posted: August 5, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/8003130fb1cc4d13b3ca577bb37a1098/view

## Description

**UPDATE 08/05/2026:** This update is to post an Amendment (A00001) which removes "Unlimited Corrective Repairs" from the requirement, and also:

1) removes FAR clause 52.219-6 Notice of Small Business Set-Aside from the document as this is solicited full and open (as per page 1 of the solicitation--see question #1 below);

2) updates the solicitation number from 75F40126Q134706 to 75F40126Q135706 (internal to the document only) (see question #2, below);

3) corrects the HHSAR clause within the requirement for the Accessibility Conformance Report (ACR) from 352.239-74 to 352.329-79. This RFQ is reopened until 08/10/2026 at 2:00pm Central time.

**UPDATE, Questions and Responses, 08/03/2026:**

**NOTE 1:** Closing date and time is not affected by the issuance of the following Questions and Answers.

**Note 2:** No correcting documents are uploaded with this update.

**Vendor Question 1:** Page 1 states that the acquisition is full and open and that businesses of any size may submit, while page 4 includes FAR 52.219-6, Notice of Total Small Business Set-Aside. Which competition status governs?

**Government's Response:** The acquisition is conducted on a full and open, unrestricted basis. Businesses of any size may submit a quotation. FAR 52.219-6 was included in error and is hereby removed from the solicitation.

**Vendor Question 2:** The SAM.gov notice details identify solicitation 75F40126Q135706, while the attached RFQ and its submission instruction identify 75F40126Q134706. Which solicitation number governs?

**Government's Response:** The correct solicitation number is 75F40126Q135706. The number listed on the attached RFQ document was a typographical error. All quotations submitted in response to this requirement must reference solicitation number 75F40126Q135706.

**Vendor Question 3:** Page 11 directs the Accessibility Conformance Report to standards identified in 352.239-74, while pages 9–10 identify 352.239-78 and 352.239-79 as the ICT accessibility provisions. Which clause or clauses should the report address?

**Government's Response:** The Information and Communication Technology (ICT) accessibility requirements for this solicitation are governed by provision HHSAR 352.239-78 (page 9 of the solicitation) and clause HHSAR 352.239-79 (page 5 of the solicitation) as detailed within the provision and clause listed in the pages just referenced. The reference to 352.239-74 on page 11 was a template holdover. Offerors must ensure their Accessibility Conformance Report (ACR) addresses the active standards identified in provision 352.239-78 and clause HHSAR 352.239-79.

End of Questions and Answers

**ORIGINAL POSTING 07/27/2026:** See attached Solicitation/Request for Quote (RFQ) for the FDA's requirement for a preventive and unlimited Corrective Repair (Essentialcare or equal) service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument for a Base plus two (2) option years

## Award on USAspending

- Recipient: Global Life Sciences Solutions USA LLC (UEI FG41DG32EGC3)
- Contract: 75F40126P00208, purchase order
- Obligated: $13,320.00
- Competition: Competed Under SAP, 1 offers received
- Link: solicitation number 75F40126Q135706 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75F40126P00208_7524_-NONE-_-NONE-/


## Publications

- July 27, 2026: Combined synopsis and solicitation, due August 3, 2026 at 2:00 PM EDT. Notice f5e36876a91e4b049226568eb0d5df1d. https://sam.gov/workspace/contract/opp/f5e36876a91e4b049226568eb0d5df1d/view
- August 3, 2026: Combined synopsis and solicitation, due August 3, 2026 at 2:00 PM EDT. Notice 32d73eea069c47f799dac87feb9692b7. https://sam.gov/workspace/contract/opp/32d73eea069c47f799dac87feb9692b7/view
- August 5, 2026: Combined synopsis and solicitation, due August 10, 2026 at 3:00 PM EDT. Notice 8003130fb1cc4d13b3ca577bb37a1098. https://sam.gov/workspace/contract/opp/8003130fb1cc4d13b3ca577bb37a1098/view

## Points of contact

- Suzanne Martella, suzanne.martella@fda.hhs.gov, 3017962383

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40126q135706.